1 MONTELUKAST SODIUM | 50 of 2090 | 5970 prescriptions Less than 1% of all prescriptions | 5110 | 1190 patients 27% of all patients | 1010 patients 23% of all patients | |
2 SPIRIVA RESPIMAT (TIOTROPIUM BROMIDE) | 110 of 1610 | 1860 prescriptions Less than 1% of all prescriptions | 1270 | 440 patients 10% of all patients | 310 patients 7% of all patients | |
3 ANORO ELLIPTA (UMECLIDINIUM BRM/VILANTEROL TR) | 350 of 1860 | 1700 prescriptions Less than 1% of all prescriptions | 1260 | 540 patients 12% of all patients | 390 patients 9% of all patients | |
4 PROAIR HFA (ALBUTEROL SULFATE) | 210 of 2000 | 1760 prescriptions Less than 1% of all prescriptions | 1480 | 780 patients 18% of all patients | 630 patients 14% of all patients | |
5 INCRUSE ELLIPTA (UMECLIDINIUM BROMIDE) | 240 of 1880 | 1400 prescriptions Less than 1% of all prescriptions | 1040 | 360 patients 8% of all patients | 250 patients 6% of all patients | |
6 STIOLTO RESPIMAT (TIOTROPIUM BR/OLODATEROL HCL) | 90 of 1220 | 1250 prescriptions Less than 1% of all prescriptions | 890 | 270 patients 6% of all patients | < 11 | |
7 FLUTICASONE PROPIONATE | 300 of 1800 | 1110 prescriptions Less than 1% of all prescriptions | | 490 patients 11% of all patients | < 11 | |
8 VENTOLIN HFA (ALBUTEROL SULFATE) | 830 of 2100 | 1170 prescriptions Less than 1% of all prescriptions | 750 | 560 patients 13% of all patients | 420 patients 9% of all patients | |
9 SPIRIVA (TIOTROPIUM BROMIDE) | 490 of 1880 | 880 prescriptions Less than 1% of all prescriptions | 590 | 230 patients 5% of all patients | < 11 | |
10 ADVAIR DISKUS (FLUTICASONE PROPION/SALMETEROL) | 610 of 2050 | 880 prescriptions Less than 1% of all prescriptions | 500 | 270 patients 6% of all patients | < 11 | |
11 FLOVENT HFA (FLUTICASONE PROPIONATE) | 50 of 820 | 690 prescriptions Less than 1% of all prescriptions | 400 | 270 patients 6% of all patients | < 11 | |
12 SYMBICORT (BUDESONIDE/FORMOTEROL FUMARATE) | 1000 of 2030 | 710 prescriptions Less than 1% of all prescriptions | 540 | 260 patients 6% of all patients | < 11 | |
13 PANTOPRAZOLE SODIUM | 200 of 1010 | 510 prescriptions Less than 1% of all prescriptions | 510 | < 11 | < 11 | |
14 BREO ELLIPTA (FLUTICASONE/VILANTEROL) | 1120 of 1900 | 470 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
15 DALIRESP (ROFLUMILAST) | 320 of 1100 | 420 prescriptions Less than 1% of all prescriptions | 250 | < 11 | < 11 | |
16 COMBIVENT RESPIMAT (IPRATROPIUM/ALBUTEROL SULFATE) | 300 of 1160 | 450 prescriptions Less than 1% of all prescriptions | 320 | < 11 | < 11 | |
17 RANITIDINE HCL | 260 of 600 | 240 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
18 PREDNISONE | 1360 of 2110 | 180 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
19 OMEPRAZOLE | 720 of 1240 | 130 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
20 PROAIR RESPICLICK (ALBUTEROL SULFATE) | 150 of 380 | 150 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
21 PROLASTIN C (ALPHA-1-PROTEINASE INHIBITOR) | 30 of 240 | 130 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
22 LETAIRIS (AMBRISENTAN) | 240 of 440 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | |
23 PULMICORT FLEXHALER (BUDESONIDE) | 100 of 240 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | |
24 CHANTIX (VARENICLINE TARTRATE) | 110 of 220 | 110 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
25 XOPENEX HFA (LEVALBUTEROL TARTRATE) | 130 of 270 | 110 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
26 METHYLPREDNISOLONE | 180 of 510 | 400 prescriptions Less than 1% of all prescriptions | 270 | 330 patients 7% of all patients | < 11 | |
27 AMOXICILLIN-CLAVULANATE POTASS (AMOXICILLIN/POTASSIUM CLAV) | 230 of 940 | 300 prescriptions Less than 1% of all prescriptions | | 280 patients 6% of all patients | < 11 | A |
28 DOXYCYCLINE MONOHYDRATE | 50 of 50 | 150 prescriptions Less than 1% of all prescriptions | | 140 patients 3% of all patients | < 11 | A |